Andrew F. Sandford
Nessuna posizione attualmente
Profilo
Andrew F.
Sandford worked as Vice President-Business Development at Catalent Pharma Solutions, Inc. from 2014 to 2020.
He also worked as Principal at Dowpharma and as VP-Communications & Business Development at Selexis SA from 2010 to 2011.
Precedenti posizioni note di Andrew F. Sandford
Società | Posizione | Fine |
---|---|---|
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | 01/01/2020 |
Dowpharma
Dowpharma Chemicals: SpecialtyProcess Industries Dowpharma Manufactures and distributes chemical, pharmaceutical, and biopharmaceutical products. It offers nucleic acid medicines, peptides, and ChelaMed radiopharmaceutical products. The company is headquartered in Cambridge, UK. | Corporate Officer/Principal | - |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
Dowpharma
Dowpharma Chemicals: SpecialtyProcess Industries Dowpharma Manufactures and distributes chemical, pharmaceutical, and biopharmaceutical products. It offers nucleic acid medicines, peptides, and ChelaMed radiopharmaceutical products. The company is headquartered in Cambridge, UK. | Process Industries |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
- Borsa valori
- Insiders
- Andrew F. Sandford